Authors:
KHOR SP
AMYX H
DAVIS ST
NELSON D
BACCANARI DP
SPECTOR T
Citation: Sp. Khor et al., DIHYDROPYRIMIDINE DEHYDROGENASE INACTIVATION AND 5-FLUOROURACIL PHARMACOKINETICS - ALLOMETRIC SCALING OF ANIMAL DATA, PHARMACOKINETICS AND TOXICODYNAMICS OF 5-FLUOROURACIL IN HUMANS, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 233-238
Authors:
CWIRLA SE
BALASUBRAMANIAN P
DUFFIN DJ
WAGSTROM CR
GATES CM
SINGER SC
DAVIS AM
TANSIK RL
MATTHEAKIS LC
BOYTOS CM
SCHATZ PJ
BACCANARI DP
WRIGHTON NC
BARRETT RW
DOWER WJ
Citation: Se. Cwirla et al., PEPTIDE AGONIST OF THE THROMBOPOIETIN RECEPTOR AS POTENT AS THE NATURAL CYTOKINE, Science, 276(5319), 1997, pp. 1696-1699
Authors:
ORR GF
MUSSO DL
KELLEY JL
JOYNER SS
DAVIS ST
BACCANARI DP
Citation: Gf. Orr et al., INHIBITION OF URIDINE PHOSPHORYLASE - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF ARYL-SUBSTITUTED (2-HYDROXYETHOXY)METHYL)-5-(3-PHENOXYBENZYL)URACIL, Journal of medicinal chemistry, 40(8), 1997, pp. 1179-1185
Authors:
CHAN JH
HONG JS
KUYPER LF
JONES ML
BACCANARI DP
TANSIK RL
BOYTOS CM
RUDOLPH SK
BROWN AD
Citation: Jh. Chan et al., SYNTHESIS OF MINO-7,8,9,10-TETRAHYDROPYRIDO[3,2-F]-QUINAZOLINES - INHIBITORS OF CANDIDA-ALBICANS DIHYDROFOLATE-REDUCTASE AS POTENTIAL ANTIFUNGAL AGENTS, Journal of heterocyclic chemistry, 34(1), 1997, pp. 145-151
Authors:
WHITLOW M
HOWARD AJ
STEWART D
HARDMAN KD
KUYPER LF
BACCANARI DP
FLING ME
TANSIK RL
Citation: M. Whitlow et al., X-RAY CRYSTALLOGRAPHIC STUDIES OF CANDIDA-ALBICANS DIHYDROFOLATE-REDUCTASE - HIGH-RESOLUTION STRUCTURES OF THE HOLOENZYME AND AN INHIBITED TERNARY COMPLEX, The Journal of biological chemistry, 272(48), 1997, pp. 30289-30298
Authors:
KUYPER LF
BACCANARI DP
JONES ML
HUNTER RN
TANSIK RL
JOYNER SS
BOYTOS CM
RUDOLPH SK
KNICK V
WILSON HR
CADDELL JM
FRIEDMAN HS
COMLEY JCW
STABLES JN
Citation: Lf. Kuyper et al., HIGH-AFFINITY INHIBITORS OF DIHYDROFOLATE-REDUCTASE - ANTIMICROBIAL AND ANTICANCER ACTIVITIES OF 7,8-DIALKYL-1,3-DIAMINOPYRROLO[3,2-F]QUINAZOLINES WITH SMALL MOLECULAR-SIZE, Journal of medicinal chemistry, 39(4), 1996, pp. 892-903
Authors:
ORR GF
MUSSO DL
BOSWELL GE
KELLEY JL
JOYNER SS
DAVIS ST
BACCANARI DP
Citation: Gf. Orr et al., INHIBITION OF URIDINE PHOSPHORYLASE - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF ARYL-SUBSTITUTED 5-BENZYLURACILS AND 1-[(2-HYDROXYETHOXY)METHYL]-5-BENZYLURACILS, Journal of medicinal chemistry, 38(19), 1995, pp. 3850-3856
Authors:
CHAN JH
HONG JS
KUYPER LF
BACCANARI DP
JOYNER SS
TANSIK RL
BOYTOS CM
RUDOLPH SK
Citation: Jh. Chan et al., SELECTIVE INHIBITORS OF CANDIDA-ALBICANS DIHYDROFOLATE-REDUCTASE - ACTIVITY AND SELECTIVITY OF 5-(ARYLTHIO)-2,4-DIAMINOQUINAZOLINE, Journal of medicinal chemistry, 38(18), 1995, pp. 3608-3616
Authors:
CAO S
BACCANARI DP
JOYNER SS
DAVIS ST
RUSTUM YM
SPECTOR T
Citation: S. Cao et al., 5-ETHYNYLURACIL (776C85) - EFFECTS ON THE ANTITUMOR-ACTIVITY AND PHARMACOKINETICS OF TEGAFUR, A PRODRUG OF 5-FLUOROURACIL, Cancer research, 55(24), 1995, pp. 6227-6230
Authors:
DAVIS ST
JOYNER SS
BACCANARI DP
SPECTOR T
Citation: St. Davis et al., 5-ETHYNYLURACIL (776C85) - PROTECTION FROM 5-FLUOROURACIL-INDUCED NEUROTOXICITY IN DOGS, Biochemical pharmacology, 48(2), 1994, pp. 233-236
Citation: Dp. Baccanari et al., 5-ETHYNYLURACIL (776C85) - A POTENT MODULATOR OF THE PHARMACOKINETICSAND ANTITUMOR EFFICACY OF 5-FLUOROURACIL, Proceedings of the National Academy of Sciences of the United Statesof America, 90(23), 1993, pp. 11064-11068